AGRONOVA acquired by AMBIENTA

Ambienta completed in July 2025 the acquisition of Agronova Biotech, the Spanish biological crop protection and nutrition company formerly known as Probelte, from Magnum Capital, at an enterprise value of more than €100–350M. The Italian sustainable investment manager invested through its fourth flagship fund and financed the purchase with a unitranche facility provided by LGT’s private debt division. Founder José Manuel Casanova and the management team reinvested and stayed in the capital as minority shareholders. At the time of the sale, Agronova generated revenue of around €100–200M and an EBITDA of approximately €10–30M. Magnum Capital had bought the company in 2021 and tripled its size over four years, buying several competitors and repositioning the business from conventional agrochemicals towards biological solutions. The sale ranked among the most profitable exits in the Spanish firm’s history and supported the fundraising for its fourth fund, led by Alberto Bermejo, shortly after it sold Metrodora to Charterhouse. For Ambienta, the purchase was its first direct investment in Spain, after entering the Nordic market the previous month and acquiring Signaturit through Namirial, in which it holds a minority stake alongside Bain Capital. The deal fitted its focus on companies whose products reduce the environmental impact of industry, in a market driven by the shift towards more sustainable farming practices. Alantra, Latham & Watkins, Roland Berger and KPMG advised Ambienta, while Magnum Capital worked with PwC and Dentons.